Stentless bioprosthetic aortic valve replacement after valve-sparing aortic root replacement  by Ikonomidis, John S. & Miller, D.Craig
Stentless bioprosthetic aortic valve replacement after valve-sparing
aortic root replacement
John S. Ikonomidis, MD, PhD, FRCS(C), and D. Craig Miller, MD, Charleston, SC, and Stanford, Calif
Preservation of the aortic valve offers advantages to acomposite valve graft (CVG) procedure in certain pa-tients with aortic root aneurysms. Failures have beennoted,1-4 however, and at present, the most durable aortic
root-sparing operation appears to be the reimplantation procedure
originally described by David and Feindel (the T. David-I opera-
tion).2,3 A tubular polyester graft sized by using David’s original
formula4 (ie, Graft diameter  [(hleaflet  2) 0.67]  [2 hAo wall])
is attached to the ventriculoaortic junction beneath the leaflet
insertion level, and the native valve is sutured inside the graft. The
coronary ostia are reimplanted as Carrel buttons. Reimplantation
operations have met with considerable clinical success3 since
1988, but durability is not perfect.3,5-7 We describe successful use
of a stentless porcine valve in a patient with severe aortic regur-
gitation (AR) after David-I–type valve-sparing aortic root replace-
ment.
Clinical Summary
A 51-year-old female nurse presented to Stanford University Med-
ical Center with heart failure symptoms caused by severe recurrent
AR. Her medical history included type I diabetes mellitus and a
family history of an uncharacterized aortic disorder that had re-
sulted in the sudden deaths of her mother, sister, grandfather, and
great-grandfather. Because of an increase in aortic root diameter
(which was only modestly dilated, 4.2 cm), mild central AR in a
trileaflet valve, and family history, she underwent a reimplantation
type of aortic valve–sparing aortic root replacement in July 1993
with a 26-mm woven, double-velour, Hemashield Dacron graft
(Medi-Tech; Boston Scientific Corp, Natick, Mass). The classic T.
David-I procedure was used. She had no complications, a dis-
charge echocardiogram showed no residual AR, and, subsequently,
she was clinically well. Three years later, mild AR was noted on
an echocardiogram, but she was free of symptoms. Four years
postoperatively, she began having mild shortness of breath with
exertion; an echocardiogram showed moderate AR. In November
1999 (61⁄3 years postoperatively), she began having more shortness
of breath and had moderate-to-severe AR on echocardiography
(Figure 1). Reoperation was recommended in January 2000. A
computed tomographic angiography scan and angiogram showed
bovine arch anatomy, no evidence of downstream aortic dilatation
or dissection, intact ascending aortic graft and coronary anastomo-
ses, and normal coronary arteries. The exact mechanism of the
severe AR could not be identified by means of echocardiography,
and moderate left ventricular (LV) dilatation and global hypoki-
nesia were also present. Because of complications of her diabetes
(peripheral neuropathy, peripheral vascular disease, and cutaneous
feet ulcers), she had an aversion to warfarin anticoagulation and
insisted on another tissue valve.
At reoperation, the old fabric graft was opened in a transverse
direction above the top of the commissures. The trileaflet aortic
valve had thickened, rolled, and retracted leaflet edges and was
excised, leaving the native aortic commissures attached to the
graft. Some thin, densely adherent pannus inside the graft was
removed, except in the regions of the coronary ostia. The anulus
and graft were both sized to 21 mm with St Jude Medical stentless
SPV obturators (St Jude Medical, Inc, St Paul, Minn). A total of
sixteen 3-0 braided polyester (Ethicon, Inc, Somerville, NJ) simple
interrupted sutures were inserted into the ventriculoaortic junction
and then into the sewing ring of a 21-mm SPV valve. The valve
was seated without difficulty. The commissures of the valve were
then anchored inside the Dacron graft with 4-0 polypropylene
sutures, taking care that both coronary ostia remained unob-
structed. The distal SPV suture line was then completed by sewing
the commissures to the Dacron graft with running 4-0 polypro-
pylene sutures. The aortic graft was repaired primarily. Pathologic
examination of the native aortic valve leaflets revealed areas of
focal fibrosis and calcification without any giant cells, foreign
body cells, or macrophages.
The patient’s hospital course was unremarkable. A follow-up
echocardiogram 12 months later showed mild LV hypertrophy
without dilatation and normal LV systolic function. The aortic root
again was normal size, and the SPV valve leaflets appeared normal
(Figure 2). There was no AR, and the maximal flow velocity across
the SPV was 2.2 m/s, corresponding to a peak transvalvular
gradient of approximately 19 mm Hg (mean gradient not calculat-
ed). The patient is clinically doing well 2 years after reoperation.
Discussion
Both the T. David reimplantation3 and the Yacoub remodeling8
valve-sparing aortic root replacement procedures provide a rea-
sonable alternative in selected patients with aortic root aneurysms
or dissections who wish to avoid anticoagulation. Durability is
excellent out to 5 to 10 years,3 but not enough patients remain at
risk beyond 10 years to base sound inferences on these data.3,8,9 On
the other hand, the long-term durability of the Yacoub-type pro-
cedure in patients with Marfan syndrome is not as satisfactory.1
Should these operations fail, surgical treatment has consisted of
either orthotopic aortic valve replacement (usually with a mechan-
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ical valve) inside the graft or total aortic root replacement with a
CVG. Because of the constraints imposed by working inside the
aortic graft, visualization and exposure are not ideal, even if one
elects the simple aortic valve replacement option, and the valve
size is usually small; conversely, redoing the entire aortic root
replacement as a CVG is a bigger operation. In this case we
describe a patient in whom it was possible to implant a stentless
porcine valve inside the aortic graft after failure of a previous T.
David-I procedure to avoid the need for anticoagulation.5,6 Al-
though a stented pericardial or porcine valve could also have been
used, only a very small bioprosthesis would have fit. Redo CVG
with either a Freestyle stentless porcine aortic root (Medtronic,
Inc, Minneapolis, Minn) or a homemade CVG with a stented
bioprosthesis would also have been reasonable options, but this
would be a much more complicated operation. The simplified
approach we used was not difficult, but the field was somewhat
crowded; of course, the size of the valve is limited by the diameter
of the graft used at the initial operation. Parenthetically, either
a scalloped subcoronary Medtronic Freestyle or a St Jude Medi-
cal SPV stentless valve could have been used here. The short-term
(2 years) clinical result in this patient argues for wider consider-
ation of this particular tissue valve alternative in what is an
Figure 1. A, Preoperative transthoracic echocardiogram (parasternal long-axis view) showing the LV outflow tract
and aortic valve anulus (arrow). B, Color Doppler flow mapping image from the same transthoracic echocardio-
gram showing severe AR (arrow).
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admittedly rare circumstance in which the patient refuses warfa-
rin or is medically noncompliant or anticoagulation is contraindi-
cated.
The reason for structural valve deterioration (SVD) of the
aortic valve is not clear. Previous reports documenting SVD after
the T. David-I operation have noted, as in our case, that the aortic
leaflets were thickened and retracted; alternatively, geometric dis-
tortion caused by technical error can cause late AR,9 or occasion-
ally, an adolescent patient can outgrow the fixed ventriculoaortic
junction with resulting stenosis.3-7 It is possible that these changes
were caused by abnormal coaptation of the aortic valve leaflets
caused by incorrect sizing of the Dacron graft6 or that the original
T. David-I technique does not create pseudosinuses in the graft (as
does the Yacoub remodeling method), such that the leaflets might
hit the graft during opening and cusp abrasion might occur. The
major potential drawback of the Yacoub technique, in our opinion,
is that the ventriculoaortic junction (or aortic anulus), being not
firmly fixed, can dilate postoperatively, causing late recurrent AR,
especially in patients with Marfan syndrome.1 Kunzelman’s engi-
neering group,10 using elegant computer-modeling studies, re-
cently postulated that the absence of pseudosinuses increases di-
astolic closing stresses on the abnormal stretched leaflets, which
Figure 2. A, Postoperative transthoracic echocardiogram (parasternal long-axis view) 12 months after reoperation
showing the LV outflow tract and aortic valve anulus (arrow). B, Same transthoracic echocardiogram showing no
aortic insufficiency by using color Doppler flow imaging.
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might predispose to premature cusp SVD. To get around this
potential problem, the Cochran modification11 of the original T.
David-I procedure, DePaulis’ modified aortic root replacement
method,12 or David’s current T. David-V technique (with graft
pleats placed at the anulus and at the tops of the commissures or
sinotubular junction) all create billowing pseudosinuses while still
retaining the advantages of valve reimplantation, including solid
fixation of the ventriculoaortic junction.
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